FDA Adverse Event Injury Summary report: N

ACCU-CHEK ® MOBILE TEST STRIPS

MDR report key: 3060163 · Received April 16, 2013

Report

Report Number
1823260-2013-02311
Event Type
Injury
Date Received
April 16, 2013
Date of Event
March 20, 2013
Report Date
April 19, 2013
Manufacturer
ROCHE DIAGNOSTICS
Product Code
LFR
PMA / PMN Number
NA
Removal / Correction Number
NA
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE EVENT OCCURRED IN (B)(6). WHILE THIS PRODUCT IS NOT SOLD IN THE UNITED STATES, IT IS LIKE OR SIMILAR TO A PRODUCT MARKETED IN THE UNITED STATES. DEVICE WILL NOT BE RETURNED.

Additional Manufacturer Narrative · 1

THE EVENT OCCURRED IN (B)(6). WHILE THIS PRODUCT IS NOT SOLD IN THE UNITED STATES, IT IS LIKE OR SIMILAR TO A PRODUCT MARKETED IN THE UNITED STATES. (B)(4).

Description of Event or Problem · 1

REPORTER STATED THAT THE CUSTOMER TESTED AND OBTAINED A VALUE OF 205 MG/DL ON THE MOBILE SYSTEM AT AN UNKNOWN TIME IN THE MORNING. THE CUSTOMER TOOK THE "NORMAL" DOSE OF PROTAPHANE (HUMAN NPH INSULIN) AT THIS TIME. IN RESPONSE TO THE HIGH RESULT, THE CUSTOMER DID NOT EAT. APPROXIMATELY 30 MINUTES LATER, THE CUSTOMER BECAME UNCONSCIOUS IN THE CAR PARK OF THE CUSTOMER'S JOB. AT AN UNKNOWN TIME, THE EMERGENCY DOCTOR ARRIVED AND OBTAINED A VALUE OF 24 MG/DL. THE CUSTOMER WAS TAKEN TO THE EMERGENCY ROOM BY AMBULANCE. THE CUSTOMER RECEIVED A GLUCOSE INFUSION. THE CUSTOMER WAS IN THE EMERGENCY ROOM FOR APPROXIMATELY 30 MINUTES AND THEN RELEASED. THE CUSTOMER IS CURRENTLY FEELING WELL. THE MANUFACTURER REQUESTED RETURN OF SUSPECT PRODUCT FOR EVALUATION; HOWEVER, THE SUSPECT STRIPS ARE NO LONGER AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
163363 ACCU-CHEK ® MOBILE TEST STRIPS BLOOD GLUCOSE MONITORING TEST STRIPS LFR ROCHE DIAGNOSTICS NA ASKU

Patients

Seq Age Sex Outcome Treatment
1 031 YR Required Intervention PROTAPHANE INSULIN DAILY INJECTION| PROTAPHANE INSULIN